Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia.
Calcitonin gene-related peptide (CGRP), a potent vasodilatory peptide present in central and peripheral neurons, is released at inflammatory sites and inhibits several macrophage, dendritic cell, and lymphocyte functions. In the present study, we investigated the role of CGRP in models of local and systemic acute inflammation and on macrophage activation induced by lipopolysaccharide (LPS). Intraperitoneal pretreatment with synthetic CGRP reduces in approximately 50% the number of neutrophils in the blood and into the peritoneal cavity 4 h after LPS injection. CGRP failed to inhibit neutrophil recruitment induced by the direct chemoattractant platelet-activating factor, whereas it significantly inhibited LPS-induced KC generation, suggesting that the effect of CGRP on neutrophil recruitment is indirect, acting on chemokine production by resident cells. Pretreatment of mice with 1 mug of CGRP protects against a lethal dose of LPS. The CGRP-induced protection is receptor mediated because it is completely reverted by the CGRP receptor antagonist, CGRP 8-37. The protective effect of CGRP correlates with an inhibition of TNF-alpha and an induction of IL-6 and IL-10 in mice sera 90 min after LPS challenge. Finally, CGRP significantly inhibits LPS-induced TNF-alpha released from mouse peritoneal macrophages. These results suggest that activation of the CGRP receptor on macrophages during acute inflammation could be part of the negative feedback mechanism controlling the extension of acute inflammatory responses.
Gomes
Rachel Novaes
RN
Laboratório de Imunofarmacologia, Departamento de Fisiologia e Farmacodinâmica, Fundação Oswaldo Cruz, Rio de Janeiro 21045-900, Brazil.
Castro-Faria-Neto
Hugo C
HC
Bozza
Patricia T
PT
Soares
Milena B P
MB
Shoemaker
Charles B
CB
David
John R
JR
Bozza
Marcelo T
MT
D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000008:administration & dosage*; D016207:Cytokines / Q000097:blood; D019446:Endotoxemia / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D007274:Injections, Intraperitoneal; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000633:toxicity; D017737:Macrophages, Peritoneal / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D009504:Neutrophils / Q000378:metabolism / Q000473:pathology; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000378:metabolism; D014665:Vasodilator Agents / Q000008:administration & dosage*
D016207:Cytokines; D008070:Lipopolysaccharides; D018015:Receptors, Calcitonin Gene-Related Peptide; D014665:Vasodilator Agents; D015740:Calcitonin Gene-Related Peptide